|
1
|
Roeben B, Schüle R, Ruf S, Bender B,
Alhaddad B, Benkert T, Meitinger T, Reich S, Böhringer J, Langhans
CD, et al: SERAC1 deficiency causes complicated HSP: Evidence from
a novel splice mutation in a large family. J Med Genet. 55:39–47.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wortmann S, Rodenburg RJ, Huizing M,
Loupatty FJ, de Koning T, Kluijtmans LA, Engelke U, Wevers R,
Smeitink JA and Morava E: Association of 3-methylglutaconic
aciduria with sensori-neural deafness, encephalopathy, and
Leigh-like syndrome (MEGDEL association) in four patients with a
disorder of the oxidative phosphorylation. Mol Genet Metab.
88:47–52. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wortmann SB, Vaz FM, Gardeitchik T,
Vissers LE, Renkema GH, Schuurs-Hoeijmakers JH, Kulik W, Lammens M,
Christin C, Kluijtmans LA, et al: Mutations in the phospholipid
remodeling gene SERAC1 impair mitochondrial function and
intracellular cholesterol trafficking and cause dystonia and
deafness. Nat Genet. 44:797–802. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Sarig O, Goldsher D, Nousbeck J,
Fuchs-Telem D, Cohen-Katsenelson K, Iancu TC, Manov I, Saada A,
Sprecher E and Mandel H: Infantile mitochondrial hepatopathy is a
cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria
type IV with sensorineural deafness, encephalopathy and Leigh-like
syndrome) caused by novel mutations in SERAC1. Am J Med Genet A.
161A:2204–2215. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Maas RR, Iwanicka-Pronicka K, Kalkan Ucar
S, Alhaddad B, AlSayed M, Al-Owain MA, Al-Zaidan HI,
Balasubramaniam S, Barić I, Bubshait DK, et al: Progressive
deafness-dystonia due to SERAC1 mutations: A study of 67 cases. Ann
Neurol. 82:1004–1015. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Radha Rama Devi A and Lingappa L: Novel
mutations in SERAC1 gene in two Indian patients presenting with
dystonia and intellectual disability. Eur J Med Genet. 61:100–103.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
IJlst L1. Loupatty FJ, Ruiter JP, Duran M,
Lehnert W and Wanders RJ: 3-Methylglutaconic aciduria type I is
caused by pathogenic variants in AUH. Am J Hum Genet. 71:1463–1466.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Wortmann SB, Kluijtmans LA, Engelke UF,
Wevers RA and Morava E: The 3-methylglutaconic acidurias: What's
new? J Inherit Metab Dis. 35:13–22. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wortmann SB, Rodenburg RJT, Jonckheere A,
de Vries MC, Huizing M, Heldt K, van den Heuvel LP, Wendel U,
Kluijtmans LA, Engelke UF, et al: Biochemical and genetic analysis
of 3-methylglutaconic aciduria type IV: A diagnostic strategy.
Brain. 132:136–146. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Houtkooper RH, Turkenburg M, Poll-The BT,
Karall D, Pérez-Cerdá C, Morrone A, Malvagia S, Wanders RJ, Kulik W
and Vaz FM: The enigmatic role of tafazzin in cardiolipin
metabolism. Biochim Biophys Acta. 1788:2003–2014. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Xu Y, Kelley RI, Blanck TJ and Schlame M:
Remodeling of cardiolipin by phospholipid transacylation. J Biol
Chem. 278:51380–51385. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bione S, D'Adamo P, Maestrini E, Gedeon
AK, Bolhuis PA and Toniolo D: A novel X-linked gene, G4.5. is
responsible for Barth syndrome. Nat Genet. 12:385–389.
1996.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Whited K, Baile MG, Currier P and Claypool
SM: Seven functional classes of Barth syndrome mutation. Hum Mol
Genet. 22:483–492. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schlame M, Kelley RI, Feigenbaum A, Towbin
JA, Heerdt PM, Schieble T, Wanders RJ, DiMauro S and Blanck TJ:
Phospholipid abnormalities in children with Barth syndrome. J Am
Coll Cardiol. 42:1994–1999. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vreken P, Valianpour F, Nijtmans LG,
Grivell LA, Plecko B, Wanders RJ and Barth PG: Defective remodeling
of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem
Biophys Res Commun. 279:378–382. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Costeff H, Elpeleg O, Apter N, Divry P and
Gadoth N: 3-Methylglutaconic aciduria in ‘optic atrophy plus’. Ann
Neurol. 33:103–104. 1993.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Elpeleg ON, Costeff H, Joseph A, Shental
Y, Weitz R and Gibson KM: 3-Methylglutaconic aciduria in the
Iraqi-Jewish ‘optic atrophy plus’ (Costeff) syndrome. Dev Med Child
Neurol. 36:167–172. 1994.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nystuen A, Costeff H, Elpeleg ON, Apter N,
Bonné-Tamir B, Mohrenweiser H, Haider N, Stone EM and Sheffield VC:
Iraqi-Jewish kindreds with optic atrophy plus (3-methylglutaconic
aciduria type 3) demonstrate linkage disequilibrium with the CTG
repeat in the 3' untranslated region of the myotonic dystrophy
protein kinase gene. Hum Mol Genet. 6:563–569. 1997.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Davey KM, Parboosingh JS, McLeod DR, Chan
A, Casey R, Ferreira P, Snyder FF, Bridge PJ and Bernier FP:
Mutation of DNAJC19, a human homologue of yeast inner mitochondrial
membrane co-chaperones, causes DCMA syndrome, a novel autosomal
recessive Barth syndrome-like condition. J Med Genet. 43:385–393.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ojala T, Polinati P, Manninen T, Hiippala
A, Rajantie J, Karikoski R, Suomalainen A and Tyni T: New mutation
of mitochondrial DNAJC19 causing dilated and noncompaction
cardiomyopathy, anemia, ataxia, and male genital anomalies. Pediatr
Res. 72:432–437. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tort F, García-Silva MT, Ferrer-Cortès X,
Navarro-Sastre A, Garcia-Villoria J, Coll MJ, Vidal E,
Jiménez-Almazán J, Dopazo J, Briones P, et al: Exome sequencing
identifies a new mutation in SERAC1 in a patient with
3-methylglutaconic aciduria. Mol Genet Metab. 110:73–77.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bonnefond A, Philippe J, Durand E,
Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I,
Vambergue A, et al: Whole-exome sequencing and high throughput
genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One.
7(e37423)2012.PubMed/NCBI View Article : Google Scholar
|
